Tanitame Akihiko, Oyamada Yoshihiro, Ofuji Keiko, Fujimoto Mika, Iwai Noritaka, Hiyama Yoichi, Suzuki Kenji, Ito Hideaki, Terauchi Hideo, Kawasaki Motoji, Nagai Kazuo, Wachi Masaaki, Yamagishi Jun-ichi
Chemistry Research Laboratories, Pharmacology and Microbiology Research Laboratories, Dainippon Pharmaceutical Co. Ltd., 33-94 Enoki, Suita, Osaka 564-0053, Japan.
J Med Chem. 2004 Jul 1;47(14):3693-6. doi: 10.1021/jm030394f.
We have previously found that a pyrazole derivative 1 possesses antibacterial activity and inhibitory activity against DNA gyrase and topoisomerase IV. Here, we synthesized new pyrazole derivatives and found that 5-[(E)-2-(5-chloroindol-3-yl)vinyl]pyrazole 16 possesses potent antibacterial activity and selective inhibitory activity against bacterial topoisomerases. Many of the synthesized pyrazole derivatives were potent against clinically isolated quinolone- or coumarin-resistant Gram-positive strains and had minimal inhibitory concentration values against these strains equivalent to those against susceptible strains.
我们之前发现吡唑衍生物1具有抗菌活性以及对DNA促旋酶和拓扑异构酶IV的抑制活性。在此,我们合成了新的吡唑衍生物,发现5-[(E)-2-(5-氯吲哚-3-基)乙烯基]吡唑16具有强效抗菌活性以及对细菌拓扑异构酶的选择性抑制活性。许多合成的吡唑衍生物对临床分离的喹诺酮或香豆素耐药革兰氏阳性菌株具有强效作用,并且对这些菌株的最低抑菌浓度值与对敏感菌株的最低抑菌浓度值相当。